RespireRx Pharmaceuticals Inc (CE) (RSPI) Share Price

Smart man. I've been on a Ihub board with him since around 2013, he's a soft basher and he has a very dismal boring life therefore he thrives on getting folks to engage in convo's . He doesn't invest money just time. Also he's tied into Ihub so he can get you banned. He got me banned on another EM play. Now why would Ihub ban a poster on a stock that technically can't be traded. When I exposed him for being a soft basher here, he immediately had me reduced to 1 post a day.

Corruption at its finest


It's the OTC, nitpicking companies on this platform is easy peasy. He doesn't take on big boards.

A Company with SEC filing obligations (RSPI meets that definition) would be required to file an 8-K to report any material agreement. The fact that this Company hasn't seen fit to meet its filings obligations would seem to render that point moot.
But please don't lose sight of the source of the original question. I'm still not hearing a response from the person who posted and to whom I asked:
"Why do they need to post an 8k and what would you expect to be in it?"
No mention of funding was made in his post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176308820

Obviously a Company can't cherry pick from the securities laws. That said, it's not unusual for a non-compliant Company to file an 8k as if its a press release, telling the public what it chooses to tell them. They CAN file an 8k but they MUST file a 10k.

How many ways can we get fuxed? I just got a milly.

Nothing really. Sometimes you just sense the cadence of contrary increase; whether that be in forum commentary or single digit transaction lots to 911 trades, among others..

Kinda when you can feel a shift in the air and know storms are approaching.

What do you mean? 

Contrarian indicators continuing to surface….

Loanranger I have you on ignore so I dont see your post . I saw where people gave you answers but you want mine so here is your reply you can pick what fits should RSPI announces mergers , news update on trials , filing to get off EM , funding , buyout , Many reasons RSPI might use a 8k to do annoucements. Everyone enjoy your weekend GLTA

A SEC Form 8-K, often called a "current report," is used by publicly traded companies to disclose significant events that are not part of their regular quarterly or annual reports. These events can include acquisitions, changes in management, bankruptcy filings, and other material changes that could affect investors' decisions.
Here's a more detailed breakdown:
Purpose:
Timely Disclosure:
8-K filings ensure that investors are informed about important company events in a timely manner, rather than waiting for the next scheduled report according to SEC.gov.
Transparency:
This form increases transparency by making material information about a company publicly available.
Market Efficiency:
By providing access to information, the 8-K helps ensure that investors can make informed decisions, which contributes to a more efficient market.
Events Reported:
Acquisitions and Dispositions: When a company buys or sells a significant asset.
Changes in Management: Appointments, resignations, or terminations of executive officers or directors.
Financial Matters: Events like bankruptcy, material impairments, or changes in auditors.
Corporate Governance: Changes in the company's charter or bylaws, or amendments to material contracts.
Other Material Events: Any other event that a reasonable investor would consider important in making an investment decision.
Filing Requirements:
Companies generally have four business days to file an 8-K after a triggering event occurs according to Warrior Trading.
These reports are filed with the Securities and Exchange Commission (SEC).
The SEC requires public companies to file 8-Ks to comply with regulations.
In essence, the 8-K is a critical tool for maintaining transparency and keeping investors informed about significant developments within publicly traded companies.

You all are still at it!!!
This is a POS!!!
You longs continue to be in denial. What fools you are!
Hahaha

You all are still at it!!!
This is a POS!!!
You longs continue to be in denial. What fools you are!
Hahaha

One thing I am really curious about is KRM-ll-81 progress in tier 3 NIH HEAL program. Will they get funding for IND submission into phase 1 for pain indications as is the tier 3 intent and if so at this point is BP and all their resources necessary to be on board? But secondary from all that they also applied for grant funding for epilepsy indication/IND enabling. What would all be required to get KRM-ll-81 to a point where they can submit an IND into phase 1 clinicals for epilepsy indications as well? And will these multiple paths for multiple indications be conducted in parallel?

We seen what kind of deal is possible with a selective gabakine with Saniona and Acadia's significant deal for upfront cash and milestones. What I could gather is Saniona funded/conducted some phase 1 studies already before that deal, but with NIH possibly supplying the funding and gabakines proven to be safe will any clinicals be needed before BP jumps in.... Preclinical profile for KRM-ll-81 may just be best in class... Or circling back is BP and their resources pretty much needed at this point to move forward?

Yeah I get it, the casino mentality…. Always a poker face, someone wins, someone loses, always outsmarting the house talking about their wins and never their losses..

A bit different than an investor mindset that wants to see dollars build and create significant and sustainable value where everyone wins and rewards continue to compound from all perspectives..

No. Just a tool for the L1

lol that's America y pay more when u can manipulate and scheme to change perception of something to your own will

Yes. This is a discovery/preclinical team and they have made little effort to attract or garner the resources to take things further…

Partnership, license, sale..

Lippa, Margolis, Radin, Cerne et al. have obviously no intention or wish to run a pharmaceuticals corporation. None whatever.

Remember the lines from Batman Begins:

Thomas Wayne: No, I work at the hospital. I leave the running of our company to much better men. Bruce Wayne - age 8: Better? Thomas Wayne: Well... more interested men.

Thinking about your thought about self funding clinicals…. Even with funding they don’t and have not acquired the resources such as seasoned leadership, no accounting, no manufacturing, no broad clinical expertise, etc, etc.,

Remember they continuously mentioned license, partnership or sale. Seems the go it alone strategy might have included a professional website to assist in attracting resources…. I think a partnership or two will surface sooner than later..

Not sure what your thought is here, but it seems that an 8-k has been used to document even just simple PR from companies. They stated they need funding for filings so however that form comes in wont an 8-k be appropriate?

So pay transaction fees on small lots hoping to entice a bigger seller while other experts are looking to accumulate..

Why not just bid higher and get your shares you want?

Maybe you get 100,000 shares for nothing but why not just pay $2500 or $3000 and get 1,000,000 shares?? Once this gets into the penny, nickel, dime range the investor out gains the scalper by a mile….

I'm hoping the poster that I asked will respond. This is the second time you've responded to a question that I asked them (you're free to do that, of course)....the first time you did so you were mistaken.
They should provide an 8-K for certain types of funding, but bigtalan made no mention of funding in the post I responded to.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176308820

Hopefully he'll answer "Why do they need to post an 8k and what would you expect to be in it?"

Nah they just screwing with the bid or ask probably some retail investor is my first guess. Attempting to secure more shares at lower PPS. Thats y we are seeing 100-1000 share sells been around otc long enough to tell. In EM lets see u sell 100 shares at 0003 dropping price from current levels 002 bc there are no major bids. Usually the asks shrinks u hope the price point will spook shareholders to the point where they feel the need to salvage any amount of their investment. Boom u get a significant discount like the 1m shares at 0007. Stock market deals with technicals yes but a lot of it is psychological.

I doubt we ever will get clarity on their EM strategy. I think a few scenarios bandied about on this forum or probably some combination of thoughts are probably getting close. No excuses but it is time for them to move forward..

Well, I'm a science guy... just wondering about that scenario and it viability. When RSPI emerges from EM, I hope we will find out why they elected to go EM.

How would that work?

Something like EndeavourRX LLC gets say the gabakine program licensed and venture capital and/or BP provides major funding to get KRM-ll-81 into phase 1 clinicals in exchange for significant equity? RSPI shareholder eventually get a distribution of shares once that entity goes public?

LT - I'm wondering if they are aiming for the equivalence of an IPO which could generate enough to self-fund clinicals and possibility a better BP deal.

I agree. The HEAL program for non opioid pain management can yield a huge BP deal, interested to find out if they are close to IND submission and phase 1 and whether or not BP inks now or needs phase 1 results.

Epilepsy is another huge indication that possibly could be similar impact congruently. They have done so many preclinical studies I wonder how quickly IND and phase 1 comes for that as well.

All this amongst a host of other activities outlined in shareholder letter.

This all could come swiftly like in a matter of months.. 5-10-20-30 pennies or more would not shock anyone who followed some story pharma stocks. And the science and preclinical efforts with this one are far superior than most referenced..

rooof!!!

Come to the OTC so I can sell at the high and leave everyone at the low baby!

.0001 closed amazed

If the right news and BP involement IMO .25 is low , I could see .5 -.75 run and depending on the pumpers groups get aboard a 1.00 is also in play.

Getting close to time to shine...

Coming weeks and months setting up for something special I hope.... GLTA.

.25+ plausible?

That seems like a swoop and scoop attempt to me 🤣 I guess someone is getting desperate!

Looks like the market is getting antsy and expecting an influx of volume/interest. Even while on this expert market. Which logic suggests that exiting the EM will also bring about great tidings for the pipeline and its development.

So is this an outlet/brokerage were USA folks can gain access to acquire shares?

lol 52 week low baby

LMAO...

There was an "expert" transaction for 1000 shares at .0001 or an entire 10 cents!!!.. Classy...or maybe Classic! They can't get off this sophisticated exchange fast enough... and move the company FORWARD.

Clearly some market participants are getting itchy and anxious to have and to hold...

.0007 x .0017

Yeah some make a big deal of those supposed "signals"...

I don't, to me they are nothing more than a wink or a smile or a wave, or passing a note in class, betting on black because the 5 previous spins were red, etc....

Could be something, could be nothing but maybe if it anything it brings some hope and optimism that the tide is and will be turning.... Excited for the next 6 months and following year here.

If RSPI finds an ampakine that effectively targets these cells , considering the potential is quite good, this would mean a multi-billion dollar molecular.

Seems fake as heck lol. But shoot get me pumped let's go 

AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism and glucose homeostasis, making it a potential therapeutic target for type 2 diabetes. Research suggests that AMPK activation can improve insulin sensitivity, enhance glucose uptake in skeletal muscle, and reduce hepatic glucose production. Several AMPK activators, including metformin and AICAR, have shown promise in treating type 2 diabetes.

"AMPK ampakine" likely refers to the interaction or relationship between AMPK and ampakines, particularly the CX-designated compounds, in a biological context, possibly related to cognitive enhancement or treatment of neurological disorders. For instance, some research suggests that ampakines like CX-717 can influence AMPK activity.

All these strange lot trades are just that IMO..

444 shares
911 shares
500 shares
5 shares
1 share!!

Must be another language…. I am waiting for 10,000,000 at .20

Oh-oh!

This morning at 9:49 911@0.0017
and yesterday at 14:10 911@0.0017. I was going to mention it for laughs but now it’s a repeat. Copy that, over.

IBKR. The L1 is accurate, but delayed 15 minutes. I've tested the accuracy in the past via multiple tickers.

Noticed this morning that there was an infamous 911 trade on this expert market with sophisticated investors...

On planet Earth, the tide always turns....

Curious what platform this is from....

Seems to me there is a ton of grey area for brokers/dealers come this July 1 new OTCID changes. If the company signals in any way that they are in the process of getting filings current and more, it seems like there would be a competition to collect the investment interest from retail and others...

I don't think there should be excuses... The science, the preclinical/clincal positioning and really the shareholder letter and activities related is really top notch and gives this company/these candidates a real chance to make life changing medicine... That is the foundation to invest in a pharma/biotech.

The communication and presentation and how the business end has handled their filing duties and trip to the EM, well not so much. But these things can swiftly be handled and corrected which hopefully we see the business end finally emerge to support it all in the coming weeks and months... A stellar pipeline coupled with a smart and better approach to communication and presentation and engagement with the investment community will lead to that transformative mid major pharma company we all envision.

Yeah. But going through the OTCID new market rules effective July 1st 2025, it makes some sense that there may not have been much for them to benefit fixing their situation, comply to the existing system, and exit the expert market back into anything else before July 1st. If they’re up to sorting anything out, getting it done so it comes on then actually doesn’t sound too crazy.

8-k is what they release when they get funding they don't press pumps first. Another reason why I invested in them.

"So give them 2 more weeks to hopefully wrap up the loose ends , post the 8k , 30-45 days to be reinstated on the new OTC ."
Why do they need to post an 8k and what would you expect to be in it?

Yeah it's in bad shape. Needs to file. Needs to get TA Verified. Best to file a Form 15 but nobody wants to listen. Its going to end up revoked with a string of digits showing -100%